Skip to content

Study comparing two Ayurvedic drugs (Nastapushpantak ras and Dashmula Trivrit siddha ghrita pana) in Udavatani Yonivyapad

A Comparative Clinical Study to evaluate efficacy of Nastapushpantak rasa and Dashumla Trivrit Siddha Ghrita pana in Management of Udavatani Yonivyapad wsr to Primary Dysmenorrhea - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107525
Enrollment
50
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

SHRI DHANWANTRI AYURVEDIC COLLEGE AND RESEARCH CENTER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with signs and symptoms of udavartani yonivyapad as described in ayurvedic text 2 Females suffering with painful menstruation for 3 consecutive cycles 3 Female age group 13 to 25

Exclusion criteria

Exclusion criteria: 1 Cases of secondary dysmenorrhea with pelvic pathology 2 patient using IUCD 3 Patient having systemic disease likely to influence menstrual cycle 4 Patient having congenital anomalies leading to dysmenorrhea

Design outcomes

Primary

MeasureTime frame
Changes in udavartani yonivyapad symptomsTimepoint: Change in udavartani yonivaypad symptoms after 1 month

Secondary

MeasureTime frame
Significant changes in symptoms of Udavartani yonivyapad and also adverse events experienced by participantsTimepoint: 3 consecutive cycles

Countries

India

Contacts

Public ContactDr Digamber P Shevale

SHRI DHANWANTARI AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE MATHURA

digs198180@gmail.com9271232369

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026